Biomarkers in translational research of Alzheimer’s Disease
- 31 October 2010
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 59 (4-5) , 310-322
- https://doi.org/10.1016/j.neuropharm.2010.04.006
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyPublished by Elsevier ,2006
- The Role of Biomarkers in Clinical Trials for Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2006
- Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and MemoryJournal of Neuroscience, 2005
- Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease☆Neurobiology of Aging, 2000
- The Magnitude of Brain Lipid Peroxidation Correlates with the Extent of Degeneration but Not with Density of Neuritic Plaques or Neurofibrillary Tangles or with APOE Genotype in Alzheimer's Disease PatientsThe American Journal of Pathology, 1999
- Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's diseaseAnnals of Neurology, 1997
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Neuropil Threads Occur in Dendrites of Tangle—Bearing Nerve CellsNeuropathology and Applied Neurobiology, 1988